Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Biocon Limited (NSE: BIOCON), ISIN INE376G01013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BIOCON last traded at ₹367.00 (+0.52%), with a 52-week range of ₹318.40 to ₹447.15 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 44.68%, FIIs 8.64%, DIIs 29.22%, mutual funds 22.08%.
EquiSense Score (ECS): 41/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.